Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management. The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.
